MedTrace Logo

Mobile Application in the Management of Mild to Moderate Postpartum Depression (PPD)

NCT05077644 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 65

Last updated 2021-10-14

No results posted yet for this study

Summary

Primary Objective: Evaluate the user experience with the Stella (TM) app for the management of Postpartum Depression in an observed population for 8 calendar weeks.

Conditions

  • Post-partum Depression

Interventions

DEVICE

Stella (TM) Mobile Application

Treatment of mild-to-moderate postpartum depression (PPD) using Cognitive Behavioral Therapy techniques.

Sponsors & Collaborators

  • Curio Digital Therapeutics, Inc.

    lead INDUSTRY

Principal Investigators

  • Stan Kachnowski, MPA, PhD · Healthcare Innovation Technology Lab

  • Sarah Chokshi, DrPH · Healthcare Innovation Technology Lab

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2021-12-31
Completion
2021-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05077644 on ClinicalTrials.gov